Song-Lin Shi Selected Research

Nuclear Matrix-Associated Proteins

7/2014	Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
7/2011	The localization of hnRNP A2/B1 in nuclear matrix and the aberrant expression during the RA-induced differentiation of human neuroblastoma SK-N-SH cells.
1/2011	Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma.
5/2010	Aberrant expression of nuclear matrix proteins during HMBA-induced differentiation of gastric cancer cells.
5/2010	The aberrant expressions of nuclear matrix proteins during the apoptosis of human osteosarcoma cells.
11/2009	Nuclear matrix protein, prohibitin, was down-regulated and translocated from nucleus to cytoplasm during the differentiation of osteosarcoma MG-63 cells induced by ginsenoside Rg1, cinnamic acid, and tanshinone IIA (RCT).
4/2009	Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Song-Lin Shi Research Topics

Disease

12	Neoplasms (Cancer) 01/2021 - 03/2006
4	Neuroblastoma 07/2011 - 04/2009
3	Stomach Neoplasms (Stomach Cancer) 07/2014 - 05/2010
3	Osteosarcoma (Osteogenic Sarcoma) 05/2010 - 01/2008
2	Adenocarcinoma 01/2011 - 03/2006
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2017
1	Fibrosis (Cirrhosis) 09/2015
1	Hepatocellular Carcinoma (Hepatoma) 09/2015
1	Inflammation (Inflammations) 09/2015
1	Virus Diseases (Viral Diseases) 09/2015
1	Liver Neoplasms (Liver Cancer) 07/2014
1	Carcinogenesis 01/2011
1	Bone Diseases (Bone Disease) 05/2010
1	Genomic Instability 01/2008

Drug/Important Bio-Agent (IBA)

7	NucleophosminIBA 12/2017 - 01/2008
7	Nuclear Matrix-Associated ProteinsIBA 07/2014 - 04/2009
5	hexamethylene bisacetamide (HMBA)IBA 07/2014 - 08/2008
4	Proteins (Proteins, Gene)FDA Link 12/2017 - 05/2010
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
3	hnRNP A2IBA 07/2011 - 05/2010
3	ProhibitinsIBA 03/2011 - 11/2009
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2011 - 04/2009
2	Messenger RNA (mRNA)IBA 01/2020 - 07/2014
2	cinnamic acidIBA 11/2009 - 01/2008
2	tanshinoneIBA 11/2009 - 01/2008
2	ginsenoside Rg1IBA 11/2009 - 01/2008
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Heterogeneous-Nuclear Ribonucleoprotein Group A-BIBA 01/2020
1	Profilins (Profilin)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017
1	Mannitol (Osmitrol)FDA LinkGeneric 09/2015
1	Amino Acids FDA Link 09/2015
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Indicators and Reagents (Reagents)IBA 09/2015
1	LipidsIBA 09/2015
1	CurcuminIBA 05/2010
1	Differentiation AntigensIBA 04/2009
1	PhosphoproteinsIBA 01/2008
1	Protective AgentsIBA 01/2008
1	Tachypleus tridentatus tachyplesin peptideIBA 03/2006
1	Butyric Acid (Butanoic Acid)IBA 03/2006

Therapy/Procedure

1	Therapeutics 05/2010
1	Lasers (Laser) 08/2008